Le Lézard
Classified in: Health
Subjects: HEALTH, LIFESTYLE, MISCELLANEOUS, MISCELLANEOUS, MISCELLANEOUS

Medela Introduces #MomsUnite4Milk Campaign to Benefit Families Across North America


McHenry, IL, June 09, 2022 (GLOBE NEWSWIRE) -- With the current formula and donor milk shortages affecting families across North America, Medela is launching a month-long #MomsUnite4Milk pumpathon and educational campaign to support moms and families who are uniting to help address this national crisis. The campaign is inspired by the incredible community of parents, who passionately support each other through their unique journeys every day.

"Families need support now, and we're committed to doing what we can to address this crisis," explains Jeff Castillo, executive vice president for the Americas at Medela. "Through this month-long pumpathon, we are offering breast milk bags and educational resources for those who want to donate their breast milk. Medela is also offering support to nonprofit milk banks so they can continue to serve the community of families who rely on them to provide the essential nutrition they need for their baby."

Breast milk strengthen's baby's immune system and can help baby fight disease and infection. Because of the current shortage, milk banks nationwide are experiencing a 20 percent uptick in demand, with that number expected to continue rising each day. Even prior to the shortage, there has been a trending rise in demand for donated breast milk for years, with a 22 percent increase alone from 2020 to 2021.

There are several ways to get involved in the #MomsUnite4Milk pumpathon campaign: 

About Medela

This effort is a part of Medela Cares, the company's corporate social responsibility program, which focuses on solutions for global issues, including maternal and infant health amidst critical transitions such as coming home from the hospital, fostering the mother-baby bond in the neonatal intensive care unit (NICU) or the return to work. In May, Medela donated to the Mother's Milk Bank of the Western Great Lakes in support of their ongoing efforts to provide families with donor breast milk. With Medela Cares' emphasis on serving the underrepresented and populations experiencing crisis, this initiative elevates the public health crises affecting families everywhere, impacted by shortages in both formula and donor breast milk. For more information about Medela Cares, visit MedelaCares.com

Through advancing research, observing natural behavior and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients and healthcare professionals in more than 100 countries all over the world.  As the healthcare choice for more than 6 million hospitals and homes across the globe, and the most trusted breast pump brand in North America*, Medela provides the leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education. Medela is dedicated to building better health outcomes, simplifying and improving life, and developing breakthroughs that help moms, babies and patients live their life to the fullest. For more information, visit www.medela.us.

*Voted most trusted breast pump brand by United States and Canadian shoppers based on the 2022 BrandSpark® American and Canadian Trust Studies

###

 

Attachment



These press releases may also interest you

at 06:32
"According to the latest BCC Research study, the demand for Medical Robotics and Computer-assisted Surgery: The Global Market is expected to grow from $11.5 billion in 2023 and is projected to reach $19.5 billion by the end of 2028, at a compound...

at 06:15
The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team...

at 06:07
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two...

at 06:05
Arrowhead Pharmaceuticals, Inc. today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the American Thoracic Society (ATS)...

at 06:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker data suggesting that ALS patients may benefit from longer-term treatment with debamestrocel...

at 06:00
Ibex Medical Analytics (Ibex), a global leader in AI-powered cancer diagnostics, and Kameda Medical Center (Kameda), a leading Japanese institute at the pinnacle of healthcare innovation, today announced the publication of a clinical study evaluating...



News published on and distributed by: